TURINI, Paola
 Distribuzione geografica
Continente #
NA - Nord America 1.144
EU - Europa 395
AS - Asia 185
AF - Africa 21
SA - Sud America 13
OC - Oceania 2
Totale 1.760
Nazione #
US - Stati Uniti d'America 1.138
IT - Italia 147
SG - Singapore 94
SE - Svezia 66
DE - Germania 48
IN - India 48
FI - Finlandia 45
CN - Cina 39
UA - Ucraina 27
TG - Togo 18
AR - Argentina 13
GB - Regno Unito 13
RU - Federazione Russa 12
BE - Belgio 11
IE - Irlanda 9
BG - Bulgaria 5
CA - Canada 5
RO - Romania 3
ZA - Sudafrica 3
DK - Danimarca 2
FR - Francia 2
IR - Iran 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GR - Grecia 1
IL - Israele 1
MX - Messico 1
NL - Olanda 1
NZ - Nuova Zelanda 1
Totale 1.760
Città #
Fairfield 152
Chandler 127
Ashburn 82
Ann Arbor 78
Singapore 71
Houston 68
Santa Clara 67
Seattle 62
Woodbridge 56
Cambridge 52
Rome 50
Wilmington 49
Princeton 28
Plano 27
Dearborn 25
Beijing 20
Boston 20
Lawrence 19
Fasano 18
Grafing 18
Helsinki 18
Lomé 18
Federal 13
San Paolo di Civitate 13
Brussels 11
Millbury 11
San Diego 11
Boardman 10
Dublin 9
Jacksonville 8
Bremen 7
Falkenstein 7
Fremont 7
New York 7
Andover 6
Milan 6
Bühl 5
Falls Church 5
Moscow 5
Sofia 5
Munich 4
Nanjing 4
Passons 4
Frosinone 3
Galdo 3
Jinan 3
Kunming 3
Muizenberg 3
Washington 3
Besana In Brianza 2
Chicago 2
Copenhagen 2
Dallas 2
Ferrara di Monte Baldo 2
Frankfurt am Main 2
London 2
Norwalk 2
Paris 2
San Mateo 2
Toronto 2
Trumbull 2
Anlu 1
Arnsberg 1
Athens 1
Auckland 1
Bern 1
Chongqing 1
Civitavecchia 1
Des Moines 1
Dubai 1
Fiesole 1
Fisciano 1
Fuzhou 1
Langfang 1
Laval 1
Massa Lombarda 1
Mexico City 1
Nuremberg 1
Obrigheim 1
Olevano Romano 1
Piacenza 1
Prague 1
San Fernando 1
San Francisco 1
San Jose 1
Sarnia 1
Savigno 1
Seversk 1
Shanghai 1
Shenyang 1
Simi Valley 1
Springfield 1
Stockholm 1
Sydney 1
Tallinn 1
Winnipeg 1
Wuhan 1
Zhongxin 1
Totale 1.362
Nome #
A novel comprehensive paradigm for the etiopathogenesis of multiple sclerosis: therapeutic approaches and future perspectives on its treatment 110
Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives 87
3-(1H-pyrrol-1-yl)-2-oxazolidinones as reversible, highly potent, and selective inhibitors of monoamine oxidase type A. 84
Simple, potent, and selective pyrrole inhibitors of monoamine oxidase types A and B 83
3-(1H-Pyrrol-2-yl)-2-oxazolidinones as novel monoamine oxidase type A inhibitors. 83
N-Benzil e N-Propargil 1H-Pirrolo-2-carbossiamidi, Semplici ed Efficaci Inibitori delle Monoamino Ossidasi. 75
Inhibitory effect of 1,3,5-triphenyl-4,5-dihydro-(1H)-pyrazole derivatives on activity of amine oxidases. 75
Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors. 74
Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors. 74
Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of N,N'-bis[2-oxo-2H-benzopyran]-3-carboxamides 73
Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives 73
Inhibition of amine oxidases activity by 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives. 72
Monoamine oxidase isoform-dependent tautomeric influence in the recognition of 3,5-diaryl pyrazole inhibitors. 69
Synthesis and biochemical evaluation of (R)-5-acyloxymethyl- and (S)-5-acylaminomethyl-3-(1H-pyrrol-1-yl)-2-oxazolidinones as new anti-monoamine oxidase (anti-MAO) agents. 68
Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: Extraction, biological analysis, and computational study 68
Inhibition of monoamine oxidase A and B by metronidazole. 61
Inhibition of Monoamine Oxidases by Coumarin-3-Acyl Derivatives: Biological Activity and Computational Study 58
The activation of beta-galactosidase by divalent and monovalent cations. Transient- and steady-state studies. 57
Design, Synthesis and Biological Evaluation of New Pyrrole MAO-B Inhibitors. 50
Studies on Novel Agents for Depression and Parkinson’s Disease. Potent Pyrrole and Indole Monoamine Oxidase Inhibitors. 49
Selective inhibition of FAD and Copper-dependent amine oxidases by N-acetylpirazole derivatives. 48
3-(1H-pyrrol-2- and –3-yl)-2-oxazolidinones as novel potent and selective monoamine oxidase type A inhibitors. 47
Potenti Inibitori delle Monoamino Ossidasi a Struttura Pirrolica ed Indolica. 46
N-Benzyl and N-propargyl 1H-pyrrole-2-carboxyamides, as simple and effective monoamine oxidase inhibitors. 46
3-(1H-pyrrol-2- and –3-yl)-2-oxazolidinones as novel potent and selective monoamine oxidase type A inhibitors. 44
N-Benzyl and N-Propargyl 1H-Pyrrole-2-carboxyamides, as Simple and Potent MAO Inhibitors. 44
Synthesis, molecular modeling studies and selective inhibitory activity against MAO of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)-pyrazole derivatives. 44
Synthesis and selective inhibitory activity against MAO of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives. 43
Totale 1.805
Categoria #
all - tutte 5.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.255


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020200 0 0 0 0 0 0 56 44 39 33 22 6
2020/2021162 22 14 6 14 5 11 7 8 27 18 10 20
2021/2022345 3 27 29 19 35 11 5 40 29 24 57 66
2022/2023390 51 78 14 54 63 40 3 23 36 5 16 7
2023/2024129 16 20 6 7 9 19 3 10 2 21 9 7
2024/2025189 19 37 19 4 64 46 0 0 0 0 0 0
Totale 1.805